Stryker shareholders elect directors, ratify auditor, approve exec compensation

1) All ten directors were elected to serve until the next Annual Meeting of Shareholders and until their successors have been duly elected and qualified based upon the following votes: Shares Name For Against Abstain Broker Non-Votes Mary K. Brainerd 280,924,694 9,067,785 211,099 30,151,420 Giovanni Caforio, M.D. 281,051,869 8,973,178 178,531 30,151,420 Kevin A. Lobo 274,120,183 15,911,380 172,015 30,151,420 Emmanuel P. Maceda 236,822,417 52,356,083 1,025,078 30,151,420 Sherilyn S. McCoy 286,213,500 3,785,435 204,643 30,151,420 Rachel Ruggeri 286,076,884 3,912,160 214,534 30,151,420 Andrew K. Silvernail 273,819,022 16,160,379 224,177 30,151,420 Lisa M. Skeete Tatum 286,148,758 3,843,335 211,485 30,151,420 Ronda E. Stryker 279,972,078 9,876,202 355,298 30,151,420 Rajeev Suri 286,085,744 3,887,285 230,549 30,151,420

2) The appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026 was ratified based upon the following votes: Shares For Against Abstain 284,664,762 35,281,102 409,134

3) The advisory vote on the resolution relating to compensation of our named executive officers was approved based upon the following votes: Shares For Against Abstain Broker Non-Votes 269,367,775 18,597,825 2,237,978 30,151,420